UBE2I and prostate carcinoma: In contrast, miR-188-5p is also shown to be an oncogenic miRNA that promotes prostate cancer cell proliferation and invasion, and take parts in aggressive progression and poor prognosis in patients with prostate cancer via inhibiting its target gene, ubiquitin-conjugating enzyme E2I (UBE2I) [37].